U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07668518) titled 'A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of KIT2014 in Patients With Moderate to Severe COPD' on June 19.
Brief Summary: Study investigating the safety, tolerability, pharmacokinetics and early efficacy with KIT2014 over 7 days of treatment in moderate to severe chronic obstructive pulmonary disease patients.
Study Start Date: July 01
Study Type: INTERVENTIONAL
Condition:
Chronic Obstructive Pulmonary Disease (COPD)
Intervention:
DRUG: KIT2014
KIT2014 will be administered by inhalation with a nebuliser
DRUG: Placebo
Placebo will be administered by inhalation with a nebuliser
Recruitment Status: NO...